Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Cancer cells achieve replicative immortality through telomere maintenance mechanisms (TMM).
• Two primary TMMs exist: telomerase activation and the alternative lengthening of telomeres (ALT) pathway.
• Targeting TMMs offers a broad therapeutic strategy against most cancer types.

Purpose of the Study:

• To review mechanistic differences between telomerase and ALT.
• To discuss current detection methods and clinical utility of TMM diagnostics.
• To explore emerging therapeutic strategies targeting both telomerase and ALT.

Main Methods:

• Review of existing literature on telomere biology and cancer.
• Analysis of diagnostic methods for telomerase and ALT.
• Examination of current and novel therapeutic strategies targeting TMMs.
• Exploration of exploiting telomere weaknesses for cancer cell death.

Main Results:

• Telomerase inhibitors face challenges in clinical application.
• No current therapies exist for ALT-driven cancers, which are aggressive.
• New strategies involve repurposing agents and exploiting telomere vulnerabilities.
• Targeting TMMs can extend beyond direct inhibition to induce cell death.

Conclusions:

• Understanding TMMs is crucial for developing effective cancer treatments.
• Targeting ALT represents a significant unmet need in oncology.
• Novel therapeutic approaches are emerging to exploit TMMs and telomere biology.
• Exploiting telomere weaknesses offers a promising avenue for cancer therapy.